Skip to main content
. Author manuscript; available in PMC: 2016 Nov 2.
Published in final edited form as: Cancer Lett. 2008 Jun 18;270(1):132–143. doi: 10.1016/j.canlet.2008.04.053

Fig. 2.

Fig. 2

Methylation of EndoG promoter/exon1 region in human prostate cancer cell lines. (A) EndoG promoter/exon1 DNA methylation measured by the McrBC-PCR screening method. (B) Quantification by densitometry. Optical density of 22Rv1 cells was considered 100%. n = 3 per group, * p <0.05 compared to 22Rv1 cells.

HHS Vulnerability Disclosure